Scinai Immunotherapeutics (SCNI) Receivables - Net (2016 - 2025)

Scinai Immunotherapeutics has disclosed Receivables - Net across 10 years of filings, most recently posting $150000.0 for Q4 2025.

• Receivables - Net for Q4 2025 came in at $150000.0, up 80.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $150000.0 (up 80.72% YoY), and the FY2025 annual result was $150000.0, up 80.72% from the prior year.
• Receivables - Net came in at $150000.0 for Q4 2025 at Scinai Immunotherapeutics, up from $139000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $2.6 billion in Q2 2021 to a low of $5830.0 in Q1 2023.
• The 5-year median for Receivables - Net is $179000.0 (2022), against an average of $240.3 million.
• Across the five-year window, Receivables - Net tumbled 99.99% in 2022 and soared 80.72% in 2025, its largest moves.
• Scinai Immunotherapeutics' Receivables - Net stood at $325000.0 in 2021, then plunged by 37.85% to $202000.0 in 2022, then sank by 97.11% to $5830.0 in 2023, then soared by 1323.67% to $83000.0 in 2024, then jumped by 80.72% to $150000.0 in 2025.
• The last three Receivables - Net figures came in at $150000.0 (Q4 2025), $139000.0 (Q2 2025), and $83000.0 (Q4 2024), per Business Quant data.